Censoring Distances Based on Labeled Cortical Distance Maps in Cortical Morphometry

TL;DR

This paper introduces a censoring method for LCDM data to better identify and localize morphometric differences in cortical structures related to neuropsychiatric disorders, demonstrated through depression studies.

Contribution

The study develops a censoring approach for LCDM distances that enhances the detection and localization of cortical morphometric differences, providing more detailed insights than traditional pooled measures.

Findings

Significant cortical thinning in VMPFC of MDD and high-risk subjects.

Censoring method effectively localizes morphometric differences.

Influence of data aggregation on results is negligible.

Abstract

Shape differences are manifested in cortical structures due to neuropsychiatric disorders. Such differences can be measured by labeled cortical distance mapping (LCDM) which characterizes the morphometry of the laminar cortical mantle of cortical structures. LCDM data consist of signed distances of gray matter (GM) voxels with respect to GM/white matter (WM) surface. Volumes and descriptive measures (such as means and variances) for each subject and the pooled distances provide the morphometric differences between diagnostic groups, but they do not reveal all the morphometric information contained in LCDM distances. To extract more information from LCDM data, censoring of the distances is introduced. For censoring of LCDM distances, the range of LCDM distances is partitioned at a fixed increment size; and at each censoring step, and distances not exceeding the censoring distance are kept. Censored LCDM distances inherit the advantages of the pooled distances. Furthermore, the analysis of censored distances provides information about the location of morphometric differences which cannot be obtained from the pooled distances. However, at each step, the censored distances aggregate, which might confound the results. The influence of data aggregation is investigated with an extensive Monte Carlo simulation analysis and it is demonstrated that this influence is negligible. As an illustrative example, GM of ventral medial prefrontal cortices (VMPFCs) of subjects with major depressive disorder (MDD), subjects at high risk (HR) of MDD, and healthy control (Ctrl) subjects are used. A significant reduction in laminar thickness of the VMPFC and perhaps shrinkage in MDD and HR subjects is observed when compared to Ctrl subjects. The methodology is also applicable to LCDM-based morphometric measures of other cortical structures affected by disease.